PIRAMAL ENTERPRISES Plunges by 5%; BSE HEALTHCARE Index Down 0.2%
March 13, 2020 11:44 AM

PIRAMAL ENTERPRISES share price has plunged 5% and is presently trading at Rs 1,070.

Meanwhile, the BSE HEALTHCARE Index is at 12,579 (down 0.2%).

Among the top losers in the BSE HEALTHCARE Index today are PIRAMAL ENTERPRISES (down 5.1%) and GLENMARK PHARMA (down 6.5%).

SUN PHARMA (up 5.7%) and BIOCON (up 4.3%) are among the top gainers today.

Over the last one year, PIRAMAL ENTERPRISES has moved down from Rs 2,574 to Rs 1,070, registering a loss of Rs 1,504 (down 58.4%)..

The BSE HEALTHCARE has moved down from 14,333 to 12,579, loss of 1,754 points (down 12.2%) during the last 12 months.

The top gainers among the BSE HEALTHCARE Index stocks during this same period were ABBOTT INDIA (up 97.0%), J.B.CHEMICALS (up 49.7%) and DR. LAL PATHLABS LTD (up 47.1%).

What About the Benchmark Indices?

The BSE Sensex is at 33,350 (down 0.8%). The top gainers among the BSE Sensex stocks today are SUN PHARMA (up 5.7%). The most traded stocks in the BSE Sensex are SBI and TATA STEEL.

In the meantime, NSE Nifty is at 9,750 (down 1.1%). SUN PHARMA (up 5.5%) and HDFC (up 4.8%) are among the top gainers in NSE Nifty.

Over the last 12 months, the BSE Sensex has moved down from 37,536 to 33,350, registering a loss of 4,186 points (down 13.33%).

PIRAMAL ENTERPRISES Financial Update...

PIRAMAL ENTERPRISES net profit stood at Rs 6 billion for the quarter ended December 2019, compared to a profit of Rs 5 billion a year ago. Net Sales rose 9.1% to Rs 38.1 billion during the period as against Rs 34.9 billion in October-December 2018.

For the year ended March 2019, PIRAMAL ENTERPRISES reported 76.2% decrease in net profit to Rs 11.5 billion compared to net profit of Rs 48.4 billion during FY18.

Revenue of the company grew 24.2% to Rs 132 billion during FY19.

The current Price to earnings ratio of PIRAMAL ENTERPRISES, based on rolling 12 month earnings, stands at 9.7x.